
    Hrach VOSKANYAN, d.b.a. Vosk International Co., Plaintiff-Appellant, v. ZAO GRUPPA PREDPRIYATIJ OST, Defendant-Appellee.
    No. 13-36055
    United States Court of Appeals, Ninth Circuit.
    Submitted February 21, 2017 
    
    Filed February 23, 2017
    Hrach Voskanyan, Pro Se
    
      Before: GOODWIN,- LEAVY, and SILVERMAN, Circuit Judges.
    
      
       The panel unanimously concludes this- case is suitable for decision without oral argument. See Fed. R. App. P. 34(a)(2).
    
   MEMORANDUM

Hrach Voskanyan, sole proprietor of Vosk International Co. (“Vosk”), appeals pro se the district court’s summary judgment in Vosk’s action appealing the U.S. Patent and Trademark Office Trademark Trial and Appeals Board’s (“TTAB”) denial of Vosk’s applications to register three trademarks. We have jurisdiction under 28 U.S.C. § 1291. We review de novo. S. Cal. Darts Ass’n v. Zaffina, 762 F.3d 921, 926 (9th Cir. 2014). We affirm.

The district court properly granted summary judgment because Vosk failed to raise a genuine dispute of material fact as to whether it had established priority of use of the relevant marks in connection with the involved goods. See id. at 930 (explaining how a party may establish “priority of use in commerce”). First, Vosk did not provide evidence that Zao Gruppa Predpriyatij Ost (“Zao”) committed any violation invalidating Zao’s 2001 priority date. See CreAgri, Inc. v. USANA Health Sci., Inc., 474 F.3d 626, 630 (9th Cir. 2007) (“[Ojnly lawful use in commerce can give rise to trademark priority.”). Second, Vosk’s contention that it acted as a buyer and subsequent owner, rather than, a distributor, of the marks in 2004 and 2006 is irrelevant to Zao’s 2001 priority date. Finally, Vosk did not provide evidence that Zao’s assignment of rights to Aqua-Life was invalid.

We reject Vosk’s contention that the district court erroneously deferred to the TTAB’s findings because, regardless of which standard of review should have applied, Vosk’s new evidence was not relevant to any disputed question of fact. See Kappos v. Hyatt, 566 U.S. 431, 132 S.Ct. 1690, 1701, 182 L.Ed.2d 704 (2012) (in an analogous scheme in patent law, “if new evidence is presented on a disputed question of fact, the district court must make de novo factual findings”). Vosk’s evidence showing that Zao may have violated FDA regulations starting in 2005 is irrelevant to the question of priority, as is its evidence purporting to show that Vosk was not Zao’s distributor in 2004 and 2005, and Vosk provided no evidence that the trademark assignment to Aqua-Life was invalid.

AFFIRMED. 
      
       This disposition is iiot appropriate for publication and is not precedent except as provided by Ninth Circuit Rule 36-3.
     